The primary goal of this UZGent sponsored clinical trial is to investigate the efficacy of sargramostim (Leukine®, Partner therapeutics). Sargramostim is a growth factor known for its beneficial effects in viral pneumonia, concerning the improvement of oxygenation. This project will look at the short -and long-term outcome of patients treated with Leukine®.